These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 12124800

  • 1. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH, Jung C, Jaques G.
    Int J Cancer; 2002 Aug 10; 100(5):520-6. PubMed ID: 12124800
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M.
    J Natl Cancer Inst; 1995 Nov 15; 87(22):1674-80. PubMed ID: 7473815
    [Abstract] [Full Text] [Related]

  • 3. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
    Zou CP, Kurie JM, Lotan D, Zou CC, Hong WK, Lotan R.
    Clin Cancer Res; 1998 May 15; 4(5):1345-55. PubMed ID: 9607596
    [Abstract] [Full Text] [Related]

  • 4. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U.
    Cancer Res; 1993 Dec 15; 53(24):6036-41. PubMed ID: 8261419
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG.
    Cancer Res; 1995 Feb 15; 55(4):853-61. PubMed ID: 7850799
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
    Shan D, Gopal AK, Press OW.
    Clin Cancer Res; 2001 Aug 15; 7(8):2490-5. PubMed ID: 11489831
    [Abstract] [Full Text] [Related]

  • 7. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL, Saito W, Dodge RK, Richtsmeier WJ, Fine RL.
    Otolaryngol Head Neck Surg; 1998 Apr 15; 118(4):464-71. PubMed ID: 9560096
    [Abstract] [Full Text] [Related]

  • 8. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM, Plante RK, Visconti V, Lau CY.
    Cancer Res; 1996 Mar 01; 56(5):1056-62. PubMed ID: 8640761
    [Abstract] [Full Text] [Related]

  • 9. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
    Sun SY, Yue P, Kelloff GJ, Steele VE, Lippman SM, Hong WK, Lotan R.
    Cancer Epidemiol Biomarkers Prev; 2001 Jun 01; 10(6):595-601. PubMed ID: 11401908
    [Abstract] [Full Text] [Related]

  • 10. Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.
    Kabbout M, Hatoum A, Abou-Lteif G, Chakroun I, Homaidan FR, Darwiche N.
    Mol Carcinog; 2004 May 01; 40(1):12-23. PubMed ID: 15108326
    [Abstract] [Full Text] [Related]

  • 11. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL.
    Clin Cancer Res; 2003 Oct 01; 9(12):4606-13. PubMed ID: 14555536
    [Abstract] [Full Text] [Related]

  • 12. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F.
    Cancer Res; 2006 Mar 15; 66(6):3238-47. PubMed ID: 16540676
    [Abstract] [Full Text] [Related]

  • 13. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
    Han HS, Kwon YJ, Park SH, Kim EJ, Rho YS, Sin HS, Um SJ.
    Int J Cancer; 2004 Mar 15; 109(1):58-64. PubMed ID: 14735468
    [Abstract] [Full Text] [Related]

  • 14. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM, Penland SN, Padilla GM, Selvan RS, Kim CS, Fine RL, Robertson CN.
    Cell Growth Differ; 1997 Jan 15; 8(1):101-11. PubMed ID: 8993839
    [Abstract] [Full Text] [Related]

  • 15. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
    Herbert BS, Sanders BG, Kline K.
    Nutr Cancer; 1999 Jan 15; 34(2):121-32. PubMed ID: 10578478
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase.
    Chiantore MV, Giandomenico V, De Luca LM.
    Biochem Biophys Res Commun; 1999 Jan 27; 254(3):636-41. PubMed ID: 9920792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
    Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A.
    Anticancer Res; 2005 Jan 27; 25(3B):1945-51. PubMed ID: 16158929
    [Abstract] [Full Text] [Related]

  • 20. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
    Zou C, Zhou J, Qian L, Feugang JM, Liu J, Wang X, Wu S, Ding H, Zou C, Liebert M, Grossman HB.
    Front Biosci; 2006 Sep 01; 11():2007-16. PubMed ID: 16720286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.